Literature DB >> 15123270

Identification of small molecule inhibitors that distinguish between non-transferrin bound iron uptake and transferrin-mediated iron transport.

Jing Xu Brown1, Peter D Buckett, Marianne Wessling-Resnick.   

Abstract

Chemical genetics is an emerging field that takes advantage of combinatorial chemical and small molecule libraries to dissect complex biological processes. Here we establish a fluorescence-based assay to screen for inhibitors of iron uptake by mammalian cells. Using this approach, we screened the National Cancer Institute's Diversity Set library for inhibitors of non-transferrin bound iron uptake. This screen identified 10 novel small molecule inhibitors of iron transport with IC(50) values that ranged from 5 to 30 microM. Of these ten compounds, only two blocked uptake of iron mediated by transferrin. Thus, this study characterizes the first small molecule inhibitors that distinguish between different pathways of iron transport.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123270     DOI: 10.1016/j.chembiol.2004.02.016

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

1.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

2.  The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro.

Authors:  Ahmed A Alkhateeb; Peter D Buckett; Andrew M Gardeck; Jonghan Kim; Shaina L Byrne; Paula G Fraenkel; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-23       Impact factor: 4.052

Review 3.  Pharmacology of iron transport.

Authors:  Shaina L Byrne; Divya Krishnamurthy; Marianne Wessling-Resnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

4.  Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake.

Authors:  Herbert A Wetli; Peter D Buckett; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2006-09

5.  Small molecule inhibitors of divalent metal transporter-1.

Authors:  Peter D Buckett; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

6.  Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation.

Authors:  Lijian Wang; Erin E Johnson; Hai Ning Shi; W Allan Walker; Marianne Wessling-Resnick; Bobby J Cherayil
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

7.  The small-molecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor.

Authors:  Lior Horonchik; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2008-07-21

Review 8.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

9.  Anticancer activity of the iron facilitator LS081.

Authors:  Zhen Li; Hiroki Tanaka; Floyd Galiano; Jonathan Glass
Journal:  J Exp Clin Cancer Res       Date:  2011-03-31

10.  Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.

Authors:  Shaina L Byrne; Peter D Buckett; Jonghan Kim; Flora Luo; Jack Sanford; Juxing Chen; Caroline Enns; Marianne Wessling-Resnick
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.